Public Release: 

Moffitt Cancer Center receives GMaP grant to strengthen cancer health disparities

The grant, supported by the National Cancer Institute, will help Moffitt foster state-of-the-art cancer research and training for scientists in 7 states and Puerto Rico

H. Lee Moffitt Cancer Center & Research Institute

TAMPA, Fla. (Feb. 25, 2016) - Moffitt Cancer Center received a grant from the National Cancer Institute Center to Reduce Cancer Health Disparities to bring together researchers, trainees, new and early-stage investigators, and community health members to identify and prioritize region-specific cancer research, education, outreach and training needs. The grant is part of the Geographical Management of Cancer Health Disparities Program (GMaP), a network of regional hubs that provide a systematic approach to facilitating collaboration, cooperation, information- and resource-sharing, and capacity-building among cancer health disparities researchers, trainees, outreach workers and organizations, with the key goal of advancing cancer health disparities research and training. Moffitt serves as the hub for GMaP Region 2, which includes more than 40 partner institutions in Alabama, Arkansas, Florida, Georgia, Louisiana, Missouri, Mississippi and Puerto Rico.

"The GMaP award provides support for a comprehensive and participatory team science approach to tackling health disparities in a region historically characterized by persistent excess cancer burden," said Clement Gwede, Ph.D., M.P.H., R.N., F.A.A.N., co-project director of GMaP Region 2 and associate member of the Health Outcomes & Behavior Program at Moffitt.

"This work nicely builds upon the region's longstanding collaborative efforts to reduce disparities through outreach, research and innovative training for underserved populations," added Cathy Meade, Ph.D., R.N., F.A.A.N, co-project director of the GMaP Region 2 and senior member of the Health Outcomes & Behavior Program at Moffitt.

In January, 25 investigators and community health educators convened in Tampa to plan and kick off these activities.

Some of GMaP activities include:

  • Trainee/Early Career Scientists Travel and Expert Grant Review Awards
  • Cancer Health Disparities Research Course
  • Collaborative Inter-institutional Research Pilot Funding
  • Regional Communications about Current Research and Training Opportunities.


For more information about GMaP and activities for partnering institutions in region 2, please contact Kimberly R. Williams at or 813-765-6502.

The GMaP Region 2 Program is supported by a grant from the National Cancer Institute (P30 CA076292-17S4).

About Moffitt Cancer Center

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. One of the three largest cancer centers in the United States based on patient volume, the Tampa-based facility is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the "Best Hospitals" for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. With more than 5,000 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit, and follow the Moffitt momentum on Facebook, Twitter and YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.